# Enzymatic and microbial routes to bioplastics: The green chemistry frontier of biopolymers

**Authors:** Giovanni Gallo, Emma Piccoli, Luca Bombardi, Martina Aulitto, Salvatore Fusco

PMC · DOI: 10.1002/2211-5463.70241 · FEBS Open Bio · 2026-03-27

## TL;DR

This review explores how microbes and enzymes can create eco-friendly bioplastics, focusing on ways to make them scalable and sustainable.

## Contribution

The paper introduces advances in engineered enzymes and cell-free systems for producing customizable bioplastics.

## Key findings

- Microbial and enzymatic methods are expanding the design of biodegradable polymers with tunable properties.
- Cell-free systems and PHA synthase engineering enable modular and programmable polymerization.
- Strategies for sustainable feedstocks and process intensification are critical for large-scale adoption.

## Abstract

The rapid escalation of global plastic consumption, coupled with the environmental impacts of petrochemical polymers, has sparked a surge of interest in bioplastics, particularly those derived from microbial and enzymatic processes. This review provides a comprehensive overview of the metabolic pathways, structural properties and emerging technological innovations shaping the next generation of bioplastics, with a particular focus on polyhydroxyalkanoates (PHA). The following sections outline the conceptual distinctions between bio‐based and biodegradable plastics, the key bacterial pathways responsible for the biosynthesis of PHA, PLA precursors, bacterial cellulose, microbial polyamides and other bio‐derived polymers. The physicochemical and morphological features of PHA‐based materials are analysed as well. These features include monomer composition, crystallinity, copolymer architecture and molecular weight. The relationship between these features and the mechanical and thermal performance of the materials is then investigated. A dedicated section is allocated to recent advances in in vitro enzymatic PHA synthesis, covering PHA synthase (PhaC) classes, engineered variants, cell‐free metabolic engineering platforms, enzyme immobilisation and surface‐display strategies that enable fully programmable and modular polymerisation. Finally, we discuss future perspectives, with particular emphasis on sustainable feedstocks, process intensification through synthetic biology, techno‐economic challenges and the regulatory landscape required for large‐scale adoption. The present review integrates biochemical, structural and bioprocessing insights to map current progress and identify strategic directions for enabling enzymatic bioplastics as scalable, customisable and environmentally sound alternatives within a circular bioeconomy framework.

Impact statementThis review highlights recent advances in microbial and enzymatic routes for producing polyhydroxyalkanoate‐based bioplastics, with emphasis on engineered enzymes and cell‐free systems. By integrating biochemical and bioprocess insights, it outlines strategies to enable scalable and sustainable biopolymer production within a circular bioeconomy.

This review highlights recent advances in microbial and enzymatic routes for producing polyhydroxyalkanoate‐based bioplastics, with emphasis on engineered enzymes and cell‐free systems. By integrating biochemical and bioprocess insights, it outlines strategies to enable scalable and sustainable biopolymer production within a circular bioeconomy.

Microbial biosynthesis and engineered enzyme platforms are expanding the design space of polyhydroxyalkanoate bioplastics. By combining fermentation, PHA synthase engineering and cell‐free modular systems, tailored biodegradable polymers can be produced with tunable properties, supporting more sustainable materials and future circular bioeconomy strategies. Created in biorender. Fusco, S. (2026) https://BioRender.com/kvvewnr.

## Linked entities

- **Proteins:** phaC (pseudo)

## Full-text entities

- **Diseases:** LPE (MESH:D007775), PHBH (MESH:C537153)
- **Chemicals:** plant oils (MESH:D010938), PBS (MESH:C089797), CO2 (MESH:D002245), lactyl-CoA (MESH:C047009), adipic acid (MESH:C029900), ATP (MESH:D000255), hexanoate (MESH:C037652), PP (MESH:D011126), polyester (MESH:D011091), cellulose (MESH:D002482), polyamides (MESH:D009757), PHBH (MESH:C115940), hydroxy acids (MESH:D006880), bioplastics (MESH:D001704), starch (MESH:D013213), polysaccharides (MESH:D011134), NADPH (MESH:D009249), diols (MESH:D011276), butyrate (MESH:D002087), PHBV (MESH:C052620), diamines (MESH:D003959), nitrogen (MESH:D009584), glucose (MESH:D005947), hydroxybutyrate (MESH:D006885), xanthan gum (MESH:C002563), sugars (MESH:D000073893), dextran (MESH:D003911), lactide (MESH:C091880), -PHA (MESH:D054813), poly(3-hydroxyvalerate (MESH:C073314), water (MESH:D014867), propionate (MESH:D011422), P (MESH:D010758), poly(3-hydroxybutyrate (MESH:C003182), ethylene glycol (MESH:D019855), Polymer (MESH:D011108), Plastics (MESH:D010969), 1,4-butanediol (MESH:C039681), 3-hydroxybutyrate (MESH:D020155), poly(lactate-co-3-hydroxybutyrate) (MESH:C000616599), 1,3-propanediol (MESH:C041787), 3HB-4HB (-), Ac (MESH:D000186), CoA (MESH:D003065), succinate (MESH:D019802), gamma-PGA (MESH:C511775), 3-hydroxyoctanoate (MESH:C101940), CH4 (MESH:D008697), PHB (MESH:C000720856), poly(ethylene terephthalate) (MESH:D011093), chloroform (MESH:D002725), 3-hydroxybutyryl-CoA (MESH:C030372), PLA (MESH:C033616), maltodextrin (MESH:C008315), alkane (MESH:D000473), 3-hydroxyvalerate (MESH:C013056), valerate (MESH:D014631), oxygen (MESH:D010100), 3-HH (MESH:C045051), polyethylene (MESH:D020959)
- **Species:** Lactobacillus (genus) [taxon 1578], Escherichia coli (E. coli, species) [taxon 562], Pseudomonas sp. (species) [taxon 306], Actinobacillus succinogenes (species) [taxon 67854], Chromobacterium sp. (species) [taxon 306190], Bacillus cereus (species) [taxon 1396], Synechocystis sp. (species) [taxon 1143], Azotobacter chroococcum (species) [taxon 353], Priestia megaterium (species) [taxon 1404], Allochromatium vinosum (species) [taxon 1049], Azohydromonas lata (species) [taxon 45677], Pseudomonas aeruginosa (species) [taxon 287], Thiococcus pfennigii (species) [taxon 1057], Pseudomonas putida (species) [taxon 303], Cupriavidus necator (species) [taxon 106590], Haloferax mediterranei (species) [taxon 2252], Aeromonas caviae (species) [taxon 648], Pseudomonas sp. PH-a (species) [taxon 1170662], Corynebacterium glutamicum (species) [taxon 1718], Komagataeibacter (genus) [taxon 1434011]
- **Mutations:** D171G, S324T, Q480K, N149S
- **Cell lines:** PhaC_Re — Mus musculus (Mouse), Hybridoma (CVCL_N292), LCL-PHA — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_8280), MCL-PHA — Homo sapiens (Human), Transformed cell line (CVCL_UU63), PhaC_Ac — Mus musculus (Mouse), Hybridoma (CVCL_XK29)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13042732/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13042732/full.md

## References

103 references — full list in the complete paper: https://tomesphere.com/paper/PMC13042732/full.md

---
Source: https://tomesphere.com/paper/PMC13042732